Segment Reporting

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Segment Reporting

Note 17– Segment Reporting

Operating segments are defined under U.S. GAAP as components of an enterprise for which discrete financial information is available and are evaluated regularly by the enterprise’s chief operating decision maker in determining how to allocate resources and assess performance. The Company operates in two reportable business segments:

● Hospital Operations, which reflects the operations of Jamestown Regional Medical Center, which we acquired on June 1, 2018 and Big South Fork Medical Center, which began operations on August 8, 2017.

● Clinical Laboratory Operations, which specializes in providing urine and blood toxicology and pain medication testing to physicians, clinics and rehabilitation facilities in the United States.

The Company’s Corporate expenses reflect consolidated company wide support services such as finance, legal counsel, human resources, and payroll.

The Company’s Decision Support and Informatics segment and its Supportive Software Solutions segment are now included in discontinued operations as they have been classified as held for sale as of December 31, 2018. The accounting policies of the reportable segments are the same as those described in Note 2.

Selected financial information for the Company’s operating segments is as follows:

		Year Ended December 31,
		2018			2017
Net revenues - External
Clinical Laboratory Operations	$	131,014		$	2,210,318
Hospital Operations		14,417,676			877,898
	$	14,548,690		$	3,088,216
Loss from operations
Clinical Laboratory Operations	$	(2,247,499	)	$	(4,672,768	)
Hospital Operations		(6,434,538	)		(4,800,539	)
Corporate		(4,542,583	)		(6,602,800	)
	$	(13,224,620	)	$	(16,076,107	)
Depreciation and amortization
Clinical Laboratory Operations	$	764,445		$	1,639,954
Hospital Operations		498,352			73,985
Corporate		1,047			1,382
	$	1,263,844		$	1,715,321
Capital expenditures
Clinical Laboratory Operations	$	-		$	-
Hospital Operations		213,105			1,422,002
	$	213,105		$	1,422,002

	Year Ended December 31,
	2018			2017
Total assets
Clinical Laboratory Operations	$	271,426		$	1,503,520
Hospital Operations		13,568,933			2,549,504
Corporate		2,707,416			3,436,773
Assets of AMSG and HTS classified as held for sale		152,171			255,566
Eliminations		(2,500,646	)		(1,454,570	)
	$	14,199,300		$	6,290,794